• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期宫颈癌患者肿瘤测量参数和 SCC-Ag 变化的预后价值。

Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer.

机构信息

Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350000, Fujian, China.

出版信息

Radiat Oncol. 2022 Jan 10;17(1):6. doi: 10.1186/s13014-021-01978-0.

DOI:10.1186/s13014-021-01978-0
PMID:35012582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8751300/
Abstract

OBJECTIVE

To investigate the prognostic relevance of specific measurement parameters such as tumor diameter, tumor volume, tumor volume reduction rate (TVRR), and changes in the squamous cell carcinoma antigen (SCC-Ag) level in patients with locally-advanced cervical cancer (LACC) undergoing concurrent radiotherapy and chemotherapy.

METHODS

This was a retrospective study of 203 patients with stage IIA-IVA cervical squamous cell carcinoma who were newly diagnosed at our hospital between January 2011 and March 2015. Clinical data and pre-and post-treatment imaging information were collected and each parameter was calculated using 3DSlicer software. The pre/post-treatment tumor diameter (TD), tumor volume (TV), SCC-Ag (SCC), and TVRR, SCC-Ag reduction rate (SCCRR) were analyzed and their prognostic relevance evaluated.

RESULTS

The median follow-up was 69 months. The 5-year overall survival (OS) and disease progression-free survival (PFS) rates were 69.5% and 64.5%, respectively. On univariate analysis, TD, TV, TVRR, SCC and SCCRR showed significant association with OS and PFS (P < 0.05). On multivariate analysis, TD [Hazard ratio (HR) = 0.373, P = 0.028], TD (HR = 0.376, P = 0.003) and SCC (HR = 0.374, P = 0.001) were independent predictors of OS. TVRR (HR = 2.998, P < 0.001), SCC (HR = 0.563, P = 0.041), and SCC (HR = 0.253, P < 0.001) were independent predictors of PFS. Tumor measurement parameters showed a positive correlation with SCC-Ag (P < 0.05).

CONCLUSION

TD, TV, TVRR, SCC, and SCCRR were prognostic factors in LACC. TD and SCC showed the most significant prognostic value. TVRR and SCC were closely related to disease progression. Further studies should investigate the correlation between measurement parameters of tumor and SCC-Ag.

摘要

目的

探讨特定测量参数在同步放化疗的局部晚期宫颈癌(LACC)患者中的预后相关性,这些参数包括肿瘤直径、肿瘤体积、肿瘤体积减少率(TVRR)和鳞状细胞癌抗原(SCC-Ag)水平的变化。

方法

这是一项回顾性研究,共纳入 203 例 2011 年 1 月至 2015 年 3 月期间在我院新诊断为宫颈鳞状细胞癌的 IIA-IVA 期患者。收集临床数据和治疗前后的影像学信息,并使用 3DSlicer 软件计算每个参数。分析治疗前后肿瘤直径(TD)、肿瘤体积(TV)、SCC-Ag(SCC)、TVRR 和 SCC-Ag 减少率(SCCRR),并评估其预后相关性。

结果

中位随访时间为 69 个月。5 年总生存率(OS)和无疾病进展生存率(PFS)分别为 69.5%和 64.5%。单因素分析显示,TD、TV、TVRR、SCC 和 SCCRR 与 OS 和 PFS 显著相关(P<0.05)。多因素分析显示,TD[风险比(HR)=0.373,P=0.028]、TD(HR=0.376,P=0.003)和 SCC(HR=0.374,P=0.001)是 OS 的独立预测因素。TVRR(HR=2.998,P<0.001)、SCC(HR=0.563,P=0.041)和 SCC(HR=0.253,P<0.001)是 PFS 的独立预测因素。肿瘤测量参数与 SCC-Ag 呈正相关(P<0.05)。

结论

TD、TV、TVRR、SCC 和 SCCRR 是 LACC 的预后因素。TD 和 SCC 具有最显著的预后价值。TVRR 和 SCC 与疾病进展密切相关。应进一步研究肿瘤测量参数与 SCC-Ag 的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da42/8751300/36d99003b3c7/13014_2021_1978_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da42/8751300/c7a63e740d79/13014_2021_1978_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da42/8751300/983b0ea39660/13014_2021_1978_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da42/8751300/36d99003b3c7/13014_2021_1978_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da42/8751300/c7a63e740d79/13014_2021_1978_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da42/8751300/983b0ea39660/13014_2021_1978_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da42/8751300/36d99003b3c7/13014_2021_1978_Fig3_HTML.jpg

相似文献

1
Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer.局部晚期宫颈癌患者肿瘤测量参数和 SCC-Ag 变化的预后价值。
Radiat Oncol. 2022 Jan 10;17(1):6. doi: 10.1186/s13014-021-01978-0.
2
Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.根治性手术治疗的宫颈鳞癌患者术前血清鳞状细胞癌抗原(SCC-Ag)水平对肿瘤复发的预测价值:单中心研究。
Eur J Surg Oncol. 2020 Jan;46(1):131-138. doi: 10.1016/j.ejso.2019.08.021. Epub 2019 Aug 27.
3
Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.治疗后鳞状细胞癌抗原作为局部晚期宫颈癌患者的生存预后因素。一项西班牙多中心研究。西班牙妇科肿瘤学会-美国妇科肿瘤学会(SEGO-Spain-GOG)组。
Gynecol Oncol. 2021 Aug;162(2):407-412. doi: 10.1016/j.ygyno.2021.06.005. Epub 2021 Jun 10.
4
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.治疗前循环单核细胞计数对宫颈癌患者的预后价值:与 SCC-Ag 水平的比较。
Gynecol Oncol. 2012 Jan;124(1):92-7. doi: 10.1016/j.ygyno.2011.09.034. Epub 2011 Oct 19.
5
Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.根治性放疗联合或不联合同期化疗治疗宫颈鳞癌患者,治疗前癌胚抗原的预后价值。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1105-13. doi: 10.1016/j.ijrobp.2010.07.011. Epub 2010 Oct 6.
6
The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.血清鳞状细胞癌抗原在接受新辅助化疗后行根治性手术的宫颈癌患者中的预测价值:一项单机构研究。
PLoS One. 2015 Apr 10;10(4):e0122361. doi: 10.1371/journal.pone.0122361. eCollection 2015.
7
Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.治疗前血清鳞状细胞癌抗原:早期宫颈癌新发现的预后因素。
J Clin Oncol. 1996 Jan;14(1):111-8. doi: 10.1200/JCO.1996.14.1.111.
8
Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.放疗后血清鳞状细胞癌抗原和原发肿瘤退缩对宫颈鳞状细胞癌的预后价值。
Cancer Biomark. 2020;29(3):327-335. doi: 10.3233/CBM-190934.
9
[Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].[血清鳞状细胞癌抗原在早期宫颈鳞状细胞癌患者中的临床意义]
Zhonghua Zhong Liu Za Zhi. 2019 May 23;41(5):357-362. doi: 10.3760/cma.j.issn.0253-3766.2019.05.007.
10
Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.根治性放化疗治疗宫颈鳞癌后,血清 SCC-Ag 水平的连续评估能否预测肿瘤复发和患者生存?一项多机构分析。
Int J Clin Oncol. 2020 Jul;25(7):1405-1411. doi: 10.1007/s10147-020-01664-3. Epub 2020 Mar 27.

引用本文的文献

1
Monitoring circulating cell-free HPV DNA in metastatic or recurrent cervical cancer: clinical significance and treatment implications.监测转移性或复发性宫颈癌中循环游离人乳头瘤病毒DNA:临床意义及治疗启示
Elife. 2025 Sep 17;13:RP101887. doi: 10.7554/eLife.101887.
2
Elevated pretreatment squamous cell Carcinoma Antigen indicates unfavorable treatment outcomes in cervical cancer patients receiving definitive radiotherapy.治疗前鳞状细胞癌抗原升高表明接受根治性放疗的宫颈癌患者治疗结果不佳。
Precis Radiat Oncol. 2023 Jul 16;7(3):173-180. doi: 10.1002/pro6.1202. eCollection 2023 Sep.
3
Prediction of lymph node metastasis in cervical cancer patients using AdaBoost machine learning model: analysis of risk factors.

本文引用的文献

1
Circulating Tumor Cells Counting Act as a Potential Prognostic Factor in Cervical Cancer.循环肿瘤细胞计数可作为宫颈癌的潜在预后因素。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820957005. doi: 10.1177/1533033820957005.
2
Evidence-Based Treatment Paradigms for Management of Invasive Cervical Carcinoma.浸润性宫颈癌管理的循证治疗模式
J Clin Oncol. 2019 Sep 20;37(27):2472-2489. doi: 10.1200/JCO.18.02303. Epub 2019 Aug 12.
3
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.《宫颈癌(第 3.2019 版)》,NCCN 肿瘤学临床实践指南。
使用AdaBoost机器学习模型预测宫颈癌患者的淋巴结转移:危险因素分析
Am J Cancer Res. 2025 Mar 15;15(3):1158-1173. doi: 10.62347/UMKG8609. eCollection 2025.
4
Serum soluble Tim‑3 is elevated in patients with cervical cancer and is higher in advanced clinical stages.宫颈癌患者血清可溶性Tim-3升高,且在临床晚期更高。
Biomed Rep. 2025 Mar 20;22(5):90. doi: 10.3892/br.2025.1968. eCollection 2025 May.
5
Prognostic implications of tumor volume reduction during radiotherapy in locally advanced cervical cancer: a risk-stratified analysis.局部晚期宫颈癌放疗期间肿瘤体积缩小的预后意义:一项风险分层分析。
Radiat Oncol. 2025 Mar 31;20(1):47. doi: 10.1186/s13014-025-02623-w.
6
Low pretreatment prognostic nutritional index predicts unfavorable survival in stage III-IVA squamous cervical cancer undergoing chemoradiotherapy.低预处理预后营养指数预示着接受放化疗的 III-IVA 期宫颈鳞癌患者生存预后不良。
BMC Cancer. 2025 Feb 28;25(1):377. doi: 10.1186/s12885-025-13752-6.
7
The treatment response evaluation through the combination of contrast-enhanced ultrasound and squamous cell carcinoma antigen in cervical cancer.通过超声造影与鳞状细胞癌抗原联合评估宫颈癌的治疗反应
Quant Imaging Med Surg. 2024 Oct 1;14(10):7587-7599. doi: 10.21037/qims-24-132. Epub 2024 Sep 26.
8
Preoperative scoring system for the prediction of risk of lymph node metastasis in cervical cancer.术前评分系统预测宫颈癌淋巴结转移风险。
Sci Rep. 2024 Oct 11;14(1):23860. doi: 10.1038/s41598-024-74871-x.
9
Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study.FIGO 2018 分期 IIICp 期宫颈癌患者转移淋巴结数量和淋巴结比值对预后的预测价值:一项多中心回顾性研究。
BMC Cancer. 2024 Aug 13;24(1):1005. doi: 10.1186/s12885-024-12784-8.
10
Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma.同期放化疗后 IIIC1 期宫颈鳞癌患者治疗前鳞状细胞癌抗原的平均对数变化率。
Sci Rep. 2024 Apr 15;14(1):8710. doi: 10.1038/s41598-024-59412-w.
J Natl Compr Canc Netw. 2019 Jan;17(1):64-84. doi: 10.6004/jnccn.2019.0001.
4
Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.根治性放化疗后宫颈鳞癌患者 SCC-Ag 水平升高对肿瘤复发和患者生存的意义:多中心分析。
J Gynecol Oncol. 2019 Jan;30(1):e1. doi: 10.3802/jgo.2019.30.e1. Epub 2018 Apr 30.
5
Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.染色体核型分析的循环肿瘤细胞作为一种新型生物标志物用于鼻咽癌的诊断和治疗。
BMC Cancer. 2018 Nov 19;18(1):1133. doi: 10.1186/s12885-018-5034-x.
6
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma.循环肿瘤细胞是预测接受胰腺和壶腹周围腺癌切除术患者生存时间更短的独立预测因子。
Ann Surg. 2020 Mar;271(3):549-558. doi: 10.1097/SLA.0000000000003035.
7
Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage.术前鳞状细胞癌抗原(SCC-Ag)和血小板增多症作为FIGO早期宫颈癌盆腔淋巴结转移的预测标志物。
J Cancer. 2018 Apr 18;9(9):1660-1666. doi: 10.7150/jca.24049. eCollection 2018.
8
The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.血清鳞状细胞癌抗原与宫颈鳞状细胞癌患者复发和生存的关系:系统评价和荟萃分析。
Gynecol Oncol. 2018 Jul;150(1):190-200. doi: 10.1016/j.ygyno.2018.03.056. Epub 2018 Mar 29.
9
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.血清鳞状细胞癌抗原作为宫颈癌治疗过程中早期反应的指标。
Br J Cancer. 2018 Jan;118(1):72-78. doi: 10.1038/bjc.2017.390. Epub 2017 Nov 7.
10
Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.放射治疗期间肿瘤大小、体积和标志物表达可预测宫颈癌患者的生存情况:一项关于KROG 16-01的多机构回顾性分析
Gynecol Oncol. 2017 Dec;147(3):577-584. doi: 10.1016/j.ygyno.2017.09.036. Epub 2017 Oct 27.